Clinical trial

Gastrointestinal and Health-related Quality of Life in Kidney Transplant…

NCT00400647 · Novartis, Industry · Completed

Key facts

NCT number NCT00400647
Title Gastrointestinal and Health-related Quality of Life in Kidney Transplant Patients Treated With Mycophenolate Mofetil
Official title A 12-week Multicenter, Randomized, Open Study to Evaluate the Effects of Enteric-coated Mycophenolate Sodium (EC-MPS) in Terms of Quality of Life in Patients With Gastrointestinal (GI) Symptoms Treated With MMF (Mycophenolate Mofetil) After Kidney Transplant.
Lead sponsor Novartis, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Maintenance Kidney Transplant
Intervention type Drug
Interventions Enteric-coated Mycophenolate sodium (EC-MPS), Mycophenolate mofetil
Enrollment 136
Start date Jul 1, 2006
Primary completion Sep 1, 2008
Completion Sep 1, 2008
First posted Nov 17, 2006
Last update posted Feb 7, 2017
Countries Switzerland

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies